Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention

Kardiologia Polska

Volumn 68, Issue 7, 2010, Pages 743-751

  Pres, Damian ^a   Ga̧sior, Mariusz ^a   Strojek, Krzysztof ^a   Gierlotka, Marek ^a   Hawranek, Michał ^a   Lekston, Andrzej ^a   Wilczek, Krzysztof ^a   Tajstra, Mateusz ^a   Gumprecht, Janusz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiogenic shock; Hyperglycaemia; Myocardial infarction

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBSERVATION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 77956664384     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Worthley MI, Shrive FM, Anderson TJ et al. Prognostic implication of hyperglycaemia in myocardial infarction and primary angioplasty. Am J Med, 2007; 120: 1-7.
2. Ga̧sior M, Stasik-Pres G, Pres D et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol, 2007; 65: 1031-1038. (Pubitemid 350096908)
3. Svensson AM, McGuire DK, Abrahamsson P et al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J, 2005; 26: 1255-12561. (Pubitemid 41435454)
4. Kosiborod M, Rathore SS, Inzucchi SE et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation, 2005; 111: 3078-3086.
5. Timmer JR, van der Horst IC, Ottervanger JP et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J, 2004; 148: 399-404.
6. Timmer JR, Ottervanger JP, de Boer MJ et al. Hyperglycaemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol, 2005; 45: 999-1002.
7. Iwakura K, Ito H, Ikushima M et al. Association between hyperglycaemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol, 2003; 41: 1-7. (Pubitemid 36044395)
8. Ishihara M, Inoue I, Kawagoe T et al. Impact of acute hyperglycaemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J, 2003; 146: 674-678.
9. Singh M, White J, Hasdai D et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO- I trial. J Am Coll Cardiol, 2007; 50: 1752-1758. (Pubitemid 47600588)
10. Lindholm MG, Køber L, Boesgaard S et al. Trandolapril Cardiac Evaluation study group. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J, 2003; 24: 258-265.
11. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med, 1985; 312: 932-936.
12. Ga̧sior M, Zȩbik T, Wasilewski J et al. In-hospital outcome of patients with acute myocardial infarction treated by immediate angioplasty with and without cardiogenic shock. Analysis from ZABRZE Registry. Folia Cardiol, 2002; 5: 425-433.
13. Hochman JS, Buller CE, Sleeper LA et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol, 2000; 36: 1063-1070.
14. Hochman JS, Sleeper LA, Webb JG et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med, 1999; 341: 625-634.
15. Zeller M, Cottin Y, Brindisi MC et al. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J, 2004; 25: 308-312.
16. Vis MM, Sjauw KD, van der Schaaf RJ et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J, 2007; 154: 1184-1190.
17. Rydén L, Standl E, Bartnik M et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J, 2007; 28: 88-136.
18. Ishihara M, Kagawa E, Inoue I et al. Impact of admission hyperglycaemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol, 2007; 99: 1674-1679.
19. Allison SP, Tomlin PJ, Chamberlain MJ. Some effects of anaesthesia and surgery on carbohydrate and fat metabolism. Br J Anaesth, 1998; 81: 273-277.
20. Clarke RS, Johnston H, Sheridan B. The influence of anaesthesia and surgery on plasma cortisol, insulin and free fatty acids. Br J Anaesth, 1970; 42: 295-299.
21. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet, 1994; 343: 155-158. (Pubitemid 124000837)
22. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest, 1971; 50: 1386-1389.
23. Ceriello A, Quagliaro L, D'Amico M et al. Acute hyperglycaemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes, 2002; 51: 1076-1082.
24. Kosuge M, Kimura K, Ishikawa T et al. Persistent hyperglycaemia is associated with left ventricular dysfunction in patients with acute myocardial infarction. Circ J, 2005; 69: 23-28.
25. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev, 2001; 22: 36-52. (Pubitemid 32187802)
26. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med, 1997; 126: 296-306.
27. Ishihara M, Kojima S, Sakamoto T et al. Acute hyperglycaemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J, 2005; 150: 814-820. (Pubitemid 41396520)
28. Morishima I, Sone T, Okumura K et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol, 2000; 36: 1202-1209.
29. Lee CH, Teo SG, Hong E et al. Impact of glycaemic control on occurrence of no-reflow and 30-day outcomes in diabetic patients undergoing primary angioplasty for myocardial infarction. J Invasive Cardiol, 2005; 17: 422-426.
30. Valente S, Lazzeri C, Vecchio S et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol, 2007; 114: 176-182.
31. Tada K, Nagao K, Tanjoh K et al. Prognostic value of blood glucose in patients with cardiogenic shock. Circ J, 2006; 70: 1064-1069. (Pubitemid 44161747)